InsiderTrades.com logo
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

LINV Insider Trading

Insider Ownership Percentage: 74.44%
Insider Buying (Last 12 Months): GBX 0
Insider Selling (Last 12 Months): £1,940,000

LendInvest Insider Trading History Chart

This chart shows the insider buying and selling history at LendInvest by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

LendInvest Share Price & Price History

Current Price: GBX 29.12
Price Change: ▼ Price Decrease of -0.88 (-2.93%)
As of 12/11/2023 06:55 AM ET

This chart shows the closing price history over time for LINV up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

LendInvest Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/3/2023Christian Edouard FaesInsiderSell2,425,000GBX 80£1,940,000
10/10/2022Roderick LockhartInsiderBuy27,111GBX 68£18,435.48
See Full Table
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for LendInvest (LON:LINV)

13.79% of LendInvest stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

LendInvest plc provides mortgage services in the United Kingdom. The company operates through Short-term lending and Buy-to-Let mortgages segments. It offers short-term, development, bridging, and buy-to-let mortgages to intermediaries, landlords, and developers. The company also offers funds, secure bonds, capital markets, co-investment, and syndication for institutional investors; self-select platform which provides access to returns on underlying property loans, as well as secured bonds for individual investors; and development and structured finance for borrowers. In addition, it provides fund management services; and holds securities. LendInvest plc was incorporated in 2012 and is based in London, the United Kingdom.
Read More on LendInvest

Today's Range

Now: GBX 29.12
Low: 29
High: 30

50 Day Range

MA: GBX 31.42
Low: 29.10
High: 41

52 Week Range

Now: GBX 29.12
Low: 28
High: 97

Volume

25,403 shs

Average Volume

73,480 shs

Market Capitalization

£41.07 million

P/E Ratio

364.00

Dividend Yield

15.00%

Beta

0.21

Who are the company insiders with the largest holdings of LendInvest?

LendInvest's top insider shareholders include:
  1. Christian Edouard Faes (Insider)
  2. Roderick Lockhart (Insider)
Learn More about top insider investors at LendInvest.
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.